### Analysis of rs876660744 in Cis-Acting Elements

The variant **rs876660744** has two alternate alleles, **A>G** and **A>T**, located on chromosome 16 at position 68811758. Below is a detailed analysis of its effects, including its potential impact on cis-acting elements.

---

### 1. Variant Identification
- **rsID**: [rs876660744](https://identifiers.org/dbsnp/rs876660744)
- **Gene**: CDH1 (Cadherin-1)
- **Location**: Chromosome 16, position 68811758
- **HGVS Notations**:
  - For A>G:
    - Genomic: `chr16:g.68811758A>G`
    - Transcript: `ENST00000261769.10:c.907A>G`
    - Protein: `ENSP00000261769.4:p.Thr303Ala`
  - For A>T:
    - Genomic: `chr16:g.68811758A>T`
    - Transcript: `ENST00000261769.10:c.907A>T`
    - Protein: `ENSP00000261769.4:p.Thr303Ser`

---

### 2. Effects on Cis-Acting Elements
Cis-acting elements are regulatory DNA sequences that influence the expression of nearby genes. Based on the retrieved data:

#### **A>G Variant**
- **Transcript Consequences**:
  - The variant is primarily a **missense mutation** in the CDH1 gene, resulting in a **Thr303Ala** amino acid change.
  - It also has **non-coding effects** in certain transcripts:
    - **ENST00000561751.1**: Classified as a **3' UTR variant** (SO:0001624), which may affect mRNA stability or binding of regulatory proteins/miRNAs.
    - **ENST00000562836.5**: Classified as a **non-coding transcript variant** (SO:0001792).

#### **A>T Variant**
- **Transcript Consequences**:
  - The variant is also a **missense mutation**, resulting in a **Thr303Ser** amino acid change.
  - Similar to the A>G variant, it has **non-coding effects**:
    - **ENST00000561751.1**: Classified as a **3' UTR variant** (SO:0001624).
    - **ENST00000562836.5**: Classified as a **non-coding transcript variant** (SO:0001792).

#### **Potential Impact on Cis-Acting Elements**
- **3' UTR Variants**: Variants in the 3' untranslated region (UTR) can disrupt binding sites for microRNAs (miRNAs) or RNA-binding proteins, potentially altering post-transcriptional regulation of CDH1 expression.
- **Non-Coding Transcript Variants**: These may affect the transcription or splicing of non-coding RNAs, which could indirectly influence the regulation of CDH1 or nearby genes.

---

### 3. Disease Associations
- **A>G Variant**:
  - Associated with **Hereditary Diffuse Gastric Adenocarcinoma (HDGC)** and **Hereditary Cancer-Predisposing Syndrome**.
  - Clinical significance: Conflicting interpretations (Benign and Uncertain Significance).
- **A>T Variant**:
  - Associated with **Hereditary Cancer-Predisposing Syndrome**.
  - Clinical significance: Likely Benign.

---

### 4. Predictive Models
- **A>G Variant**:
  - SIFT: 0.01 (Deleterious)
  - PolyPhen: 0.013 (Benign)
  - AlphaMissense: 0.0839 (Low pathogenicity)
- **A>T Variant**:
  - SIFT: 1.0 (Tolerated)
  - PolyPhen: 0.048 (Benign)
  - AlphaMissense: 0.0773 (Low pathogenicity)

---

### 5. Literature Evidence
No specific studies were retrieved that directly address the impact of rs876660744 on cis-acting elements. However, its location in the 3' UTR and non-coding regions suggests potential regulatory effects.

---

### 6. TogoVar Link
- [TogoVar Page for rs876660744](https://togovar.org)

---

### Conclusion
The **rs876660744** variant may influence cis-acting elements, particularly through its effects on the 3' UTR of the CDH1 gene. This could alter mRNA stability or regulatory protein/miRNA binding. However, further experimental studies are needed to confirm these effects.

---

### 日本語での説明

#### 1. バリアントの特定
- **rsID**: [rs876660744](https://identifiers.org/dbsnp/rs876660744)
- **遺伝子**: CDH1 (カドヘリン-1)
- **位置**: 染色体16、68811758番
- **HGVS表記**:
  - A>G:
    - ゲノム: `chr16:g.68811758A>G`
    - トランスクリプト: `ENST00000261769.10:c.907A>G`
    - タンパク質: `ENSP00000261769.4:p.Thr303Ala`
  - A>T:
    - ゲノム: `chr16:g.68811758A>T`
    - トランスクリプト: `ENST00000261769.10:c.907A>T`
    - タンパク質: `ENSP00000261769.4:p.Thr303Ser`

---

#### 2. シス作用エレメントへの影響
- **A>Gバリアント**:
  - **3' UTR変異**: mRNAの安定性やmiRNA/タンパク質の結合に影響を与える可能性。
  - **非コード領域変異**: CDH1や近隣遺伝子の転写やスプライシングに影響を与える可能性。
- **A>Tバリアント**:
  - 同様に、3' UTRおよび非コード領域での影響が考えられる。

---

#### 3. 疾患との関連
- **A>Gバリアント**:
  - **遺伝性びまん性胃腺癌 (HDGC)** および **遺伝性がん素因症候群** に関連。
  - 臨床的意義: 良性および不明確な意義の解釈。
- **A>Tバリアント**:
  - **遺伝性がん素因症候群** に関連。
  - 臨床的意義: おそらく良性。

---

#### 4. 予測モデル
- **A>Gバリアント**:
  - SIFT: 0.01 (有害)
  - PolyPhen: 0.013 (良性)
  - AlphaMissense: 0.0839 (低病原性)
- **A>Tバリアント**:
  - SIFT: 1.0 (許容)
  - PolyPhen: 0.048 (良性)
  - AlphaMissense: 0.0773 (低病原性)

---

#### 5. 文献証拠
シス作用エレメントへの直接的な影響を示す研究は見つかりませんでしたが、3' UTRおよび非コード領域での位置から、調節的な影響が考えられます。

---

#### 6. TogoVarリンク
- [TogoVarページ (rs876660744)](https://togovar.org)

---

#### 結論
**rs876660744**は、特にCDH1遺伝子の3' UTRにおいて、mRNAの安定性や調節タンパク質/miRNAの結合に影響を与える可能性があります。ただし、これらの影響を確認するにはさらなる実験的研究が必要です。